Literature DB >> 20560047

MicroRNAs in cardiovascular diseases: biology and potential clinical applications.

Reena V Kartha1, Subbaya Subramanian.   

Abstract

Cardiovascular diseases represent one of the major causes for increasing rates of human morbidity and mortality across the world. This reinforces the necessity for the development of novel diagnostics and therapies for the early identification and cure of heart diseases. MicroRNAs are evolutionarily conserved small regulatory non-coding RNAs that regulate the expression of large number of genes. They are involved in several cellular pathophysiological pathways and have been shown to play a significant role in the pathogenesis of many disease states. Recent studies have correlated dysregulated miRNA expressions to diseased hearts and also shown the relevance of miRNA in growth, development, function, and stress responsiveness of the heart. The possibility of exploiting miRNAs to develop diagnostic markers or manipulating them to obtain therapeutic effects is very attractive since they have very specific targets in a particular cellular pathway. In this review we will summarize the role played by miRNAs in the heart and discuss the scope of utilizing miRNA-based strategies in the clinics for the benefit of mankind.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20560047     DOI: 10.1007/s12265-010-9172-z

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  137 in total

1.  Substrate requirements for let-7 function in the developing zebrafish embryo.

Authors:  Wigard P Kloosterman; Erno Wienholds; René F Ketting; Ronald H A Plasterk
Journal:  Nucleic Acids Res       Date:  2004-12-07       Impact factor: 16.971

2.  An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.

Authors:  Ning Liu; Andrew H Williams; Yuri Kim; John McAnally; Svetlana Bezprozvannaya; Lillian B Sutherland; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

Review 3.  Getting to the root of miRNA-mediated gene silencing.

Authors:  Ana Eulalio; Eric Huntzinger; Elisa Izaurralde
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

4.  New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites.

Authors:  Inhan Lee; Subramanian S Ajay; Jong In Yook; Hyun Sil Kim; Su Hyung Hong; Nam Hee Kim; Saravana M Dhanasekaran; Arul M Chinnaiyan; Brian D Athey
Journal:  Genome Res       Date:  2009-03-31       Impact factor: 9.043

5.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

6.  Short RNAs repress translation after initiation in mammalian cells.

Authors:  Christian P Petersen; Marie-Eve Bordeleau; Jerry Pelletier; Phillip A Sharp
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

7.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

8.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms.

Authors:  Carlos M Loya; Cecilia S Lu; David Van Vactor; Tudor A Fulga
Journal:  Nat Methods       Date:  2009-11-15       Impact factor: 28.547

10.  Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.

Authors:  Coen van Solingen; Leonard Seghers; Roel Bijkerk; Jacques M G J Duijs; Marko K Roeten; Annemarie M van Oeveren-Rietdijk; Hans J Baelde; Matthieu Monge; Joost B Vos; Hetty C de Boer; Paul H A Quax; Ton J Rabelink; Anton Jan van Zonneveld
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

View more
  18 in total

1.  Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling.

Authors:  Joshua E Babiarz; Morgane Ravon; Sriram Sridhar; Palanikumar Ravindran; Brad Swanson; Hans Bitter; Thomas Weiser; Eric Chiao; Ulrich Certa; Kyle L Kolaja
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

2.  Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

Authors:  Michael R Zile; Shannon M Mehurg; Jazmine E Arroyo; Robert E Stroud; Stacia M DeSantis; Francis G Spinale
Journal:  Circ Cardiovasc Genet       Date:  2011-09-28

Review 3.  [Epigenetics and pain].

Authors:  E Niederberger
Journal:  Anaesthesist       Date:  2014-01       Impact factor: 1.041

Review 4.  Non-coding RNAs as regulators of gene expression and epigenetics.

Authors:  Minna U Kaikkonen; Michael T Y Lam; Christopher K Glass
Journal:  Cardiovasc Res       Date:  2011-05-09       Impact factor: 10.787

Review 5.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

6.  The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells.

Authors:  Joshua M Boucher; Sarah M Peterson; Sumithra Urs; Chunxiang Zhang; Lucy Liaw
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

7.  MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.

Authors:  Jianyin Long; Yin Wang; Wenjian Wang; Benny H J Chang; Farhad R Danesh
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

8.  Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.

Authors:  Eoin P Brennan; Karen A Nolan; Emma Börgeson; Oisín S Gough; Caitríona M McEvoy; Neil G Docherty; Debra F Higgins; Madeline Murphy; Denise M Sadlier; Syed Tasadaque Ali-Shah; Patrick J Guiry; David A Savage; Alexander P Maxwell; Finian Martin; Catherine Godson
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

Review 9.  Molecular mechanisms of diabetic cardiomyopathy.

Authors:  Heiko Bugger; E Dale Abel
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

Review 10.  Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.

Authors:  Brahmanaidu Parim; V V Sathibabu Uddandrao; Ganapathy Saravanan
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.